15 unknown. 15 Phase 2, 4 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Unknown 15 |
| Phase 1 | 4 | Unknown 4 |
| Phase 3 | 2 | Unknown 2 |
Follow Chronic Obstructive Pulmonary Disease: new trials by email Literature Review of Chronic Obstructive Pulmonary Disease trials Research Report on Chronic Obstructive Pulmonary Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biological Effects of Quercetin in COPD Phase II Quercetin 1000 mg, Quercetin 500 MG, Placebo - Chronic Obstructive Pulmonary Disease, Emphysema | Phase 2 | Unknown | Temple University | 30 | 2023-11-01 | 2024-04-08 |
| Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease Bronpass Tab., Placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Unknown | Hanlim Pharm. Co., Ltd. | 96 | 2023-06-01 | 2024-05-30 |
| Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases AntiSARS-CoV-2 Serum, Placebo - Immunosuppression, Cancer | Phase 1 / Phase 2 | Unknown | Butantan Institute | 618 | 2021-05-01 | 2021-04-08 |
| High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery High flow nasal cannula, CONTROL - Chronic Obstructive Pulmonary Disease, Respiratory Failure | Phase 2 | Unknown | Alexandria University | 60 | 2020-08-01 | 2020-08-20 |
| Biological Effects of Quercetin in COPD Quercetin - Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | Unknown | Temple University | 29 | 2019-10-01 | 2023-08-16 |
| Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness Exercise training with morphine, Exercise training with placebo - Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease | Phase 2 | Unknown | Dennis Jensen, Ph.D. | 40 | 2019-08-06 | 2019-08-16 |
| This Study Include Chronic Obstructive Pulmonary Disease(COPD) Patients . Patients Were Vitamin D Deficient Age Range 40 to 80 Years, Smokers Patients Were Advised to Take Either Placebo or Vitamin D3 . Antioxidant Enzymes Were Assessed at Baseline and at 26th Weeks. cholecalciferol, Placebo oral capsule - Chronic Obstructive Pulmonary Disease | Phase 2 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 40 | 2019-03-01 | 2019-07-09 |
| Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial Ferric Carboxymaltose, Sodium Chloride 0.9% - Chronic Obstructive Pulmonary Disease | Phase 2 | Unknown | Royal Brompton & Harefield NHS Foundation Trust | 40 | 2017-04-01 | 2017-05-12 |
| Autologous Bronchial Basal Cells Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD) Bronchial basal cell - Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 20 | 2017-03-01 | 2017-03-28 |
| A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota Fluticasone group, Budesonide group, Formoterol group - Chronic Obstructive Pulmonary Disease | Phase 2 | Unknown | University of British Columbia | 69 | 2015-02-01 | 2020-03-30 |
| Muscle Training Effectiveness in the Degree of Dyspnea and Aerobic Capacity in COPD Physiotherapy, Yoga - Chronic Obstructive Pulmonary Disease, Dyspnea | Phase 1 / Phase 2 | Unknown | CES University | 44 | 2010-06-01 | 2012-06-26 |
| Maintenance Schedules Following Pulmonary Rehabilitation Pulmonary Intervention - Chronic Obstructive Pulmonary Disease, Pulmonary Rehabilitation | Phase 2 | Unknown | University of East Anglia | 128 | 2009-06-01 | 2011-08-04 |
| Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study) AKL1 - Obstructive Lung Disease, Chronic Obstructive Pulmonary Disease | Phase 2 / Phase 3 | Unknown | University of East Anglia | 164 | 2009-06-01 | 2011-08-05 |
| IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study IMD-1041, Placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Unknown | Institute of Medicinal Molecular Design, Inc. | 50 | 2008-07-01 | 2009-04-23 |
| Anticipatory & Preventive Team Care (APTCare): At Risk Patients of Family Health Networks Self-management of chronic illness - Diabetes, Chronic Obstructive Pulmonary Disease | Phase 2 / Phase 3 | Unknown | C. T. Lamont Primary Care Research Centre | 240 | 2006-10-13 |
Pulmonary Disease, Chronic Obstructive (15) · Diabetes Mellitus (2) · Dyspnea (2) · Airway Obstruction (1) · Asthma (1) · COVID-19 (1) · Cardiovascular Diseases (1) · Emphysema (1) · Heart Failure (1) · Hypertension (1) · Inflammation (1) · Kidney Diseases (1) · Lung Diseases, Interstitial (1) · Lung Diseases, Obstructive (1) · Motor Activity (1)
Chronic Disease (15) · Disease Attributes (15) · Lung Diseases (15) · Pathologic Processes (15) · Pathological Conditions, Signs and Symptoms (15) · Respiratory Tract Diseases (15) · Lung Diseases, Obstructive (14) · Respiration Disorders (4) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2) · Behavior (1)
Quercetin (2) · Budesonide, Formoterol Fumarate Drug Combination (1) · Calcitriol (1) · Cholecalciferol (1) · Exercise (1) · Fluticasone-Salmeterol Drug Combination (1) · Formoterol Fumarate (1) · IMD-1041 (1) · Morphine (1) · Physical Therapy Modalities (1) · Sodium Chloride (1) · Vitamin D (1) · Yoga (1) · ferric carboxymaltose (1)
Temple University (2) · University of East Anglia (2) · Alexandria University (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Butantan Institute (1) · C. T. Lamont Primary Care Research Centre (1) · CES University (1) · Dennis Jensen, Ph.D. (1) · Hanlim Pharm. Co., Ltd. (1) · Institute of Medicinal Molecular Design, Inc. (1) · Nanfang Hospital, Southern Medical University (1) · Royal Brompton & Harefield NHS Foundation Trust (1) · University of British Columbia (1)
United Kingdom (4) · Canada (3) · United States (2) · Bangladesh (1) · Brazil (1) · China (1) · Egypt (1) · South Korea (1)
Andrew Wilson, MD MRCP (UK) (1) · Andrew Wilson, MD, MRCP (UK) (1) · Dennis Jensen, Ph.D (1) · Don Sin, MD (1) · Jacques Lemelin, MD (1) · Kwang Ha Yoo, MD, PhD (1) · Michael Polkey, MRCP, PhD (1) · Nathalia Suarez, Profesional (1) · Nathaniel Marchetti (1) · Nathaniel Marchetti, D.O. (1) · Paul Ford, MB, BS, MRCP, PhD (1) · Rehab A. Abd Elaziz, Ass.Prof. (1) · Ricardo Palacios, MD, PhD (1) · Taskina Ali, MBBS,M.Phil (1) · Wei Zuo, Ph. D. (1)
PMID 20920189, PMID 22465313, PMID 29975735, PMID 20008582, PMID 20090057, PMID 20154234, PMID 22893340, PMID 25762226, PMID 32071149, PMID 34464242, PMID 34610114, PMID 35740433, PMID 37546740, PMID 38468259
R33AT009991 (2), 2016 (1)